Gpr171 regulates embryonic hematopoietic stem cell emergence via ERK1/2 and Notch signaling
Proceedings of the National Academy of Sciences · 2026
DOI: 10.1073/pnas.2516989123 ↗Kurz gefasst
Fachartikel in der Zeitschrift Proceedings of the National Academy of Sciences, 2026. Verfasst von Kun Zhou und 5 weiteren Autor:innen. Beteiligte Einrichtung: Key Laboratory of Animal Virology, Ministry of Agricultural and Rural Affairs of China and Zhejiang Provincial Engineering Research Center of Animal …. Hauptthemen laut MEDLINE: Hematopoietic Stem Cells, Receptors, G-Protein-Coupled, Receptors, Notch, MAP Kinase Signaling System. Die Arbeit nennt 82 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC-ND 4.0). Gefördert von: MOST | National Natural Science Foundation of China (NSFC).
Abstract (Originalsprache)
Hematopoietic stem cells (HSCs), which sustain lifelong blood cell production, emerge from hemogenic endothelium during embryonic development through the regulation of multiple signaling pathways. However, generating functional HSCs in vitro remains challenging, underscoring gaps in understanding the underlying mechanisms. Here, we identify GPR171, a P2Y-family G-protein-coupled receptor (GPCR), as a critical regulator of vertebrate embryonic HSC specification. Gpr171 is highly expressed in hemogenic endothelium and hematopoietic stem and progenitor cells. A deficiency in Gpr171 results in severe embryonic HSC deficits but does not impair vasculogenesis and primitive hematopoiesis. We further find that its endogenous ligand, coded by pcsk1nl , cooperates with Gpr171 to enhance HSC generation. Mechanistically, Gpr171 activates ERK1/2 and Notch signaling pathways independently and synergistically to promote HSC generation. Pharmacological treatment of zebrafish embryos with the human GPR171 ligand BigLEN significantly increases HSC numbers. Moreover, GPR171 signaling is evolutionarily conserved, as GPR171-deficient murine embryos also exhibit a significant reduction in functional HSCs. Overall, our findings reveal GPR171 as an evolutionarily conserved regulator of embryonic HSC specification and suggest its potential for translational applications in stem cell–based therapeutics.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Key Laboratory of Animal Virology, Ministry of Agricultural and Rural Affairs of China and Zhejiang Provincial Engineering Research Center of Animal Biological Products, Department of Veterinary Medicine, Zhejiang Unive…
- Center for Genetic Medicine, the Fourth Affiliated Hospital of School of Medicine, and International School of Medicine, Zhejiang University, Yiwu, Zhejiang 322000, China.
- Institute of Genetics, Department of Human Genetics, Zhejiang University School of Medicine, Hangzhou, Zhejiang 310058, China.
- Hainan Institute of Zhejiang University, Sanya, Hainan 572025, China.
ORCID-Profile: Peng-Fei Xu, Yan Li
Förderung
- MOST | National Natural Science Foundation of China (NSFC)
Zitieren
APA
Zhou, K., Liu, H., Zhu, K., Yu, L., Xu, P. F., & Li, Y. (2026). Gpr171 regulates embryonic hematopoietic stem cell emergence via ERK1/2 and Notch signaling. Proceedings of the National Academy of Sciences. https://doi.org/10.1073/pnas.2516989123
Vancouver
Zhou K, Liu H, Zhu K, Yu L, Xu PF, Li Y. Gpr171 regulates embryonic hematopoietic stem cell emergence via ERK1/2 and Notch signaling. Proceedings of the National Academy of Sciences. 2026. doi:10.1073/pnas.2516989123
BibTeX
@article{Zhou2026,
author = {Zhou, Kun and Liu, Hongyan and Zhu, Kai and Yu, Longhai and Xu, Peng-Fei and Li, Yan},
title = {Gpr171 regulates embryonic hematopoietic stem cell emergence via ERK1/2 and Notch signaling},
journal = {Proceedings of the National Academy of Sciences},
year = {2026},
doi = {10.1073/pnas.2516989123}
}
EUVIMED